CpG oligodeoxynucleotides stimulate cord blood mononuclear cells to produce immunoglobulins

Cheri D Landers1, Subbarao Bondada

  • 1Department of Pediatrics, Division of Pediatric Critical Care, 800 Rose Street, Room MN478, University of Kentucky, Lexington, KY 40536, USA. cdland2@uky.edu

Insights

CpG oligodeoxynucleotides (ODNs) stimulate neonatal B cells to produce IgM, similar to adults. However, cord blood cells show reduced IgG and no IgA production, suggesting potential as neonatal vaccine adjuvants for polysaccharide antigens.

Area of Science:

  • Immunology
  • Neonatal Immunity

Background:

  • CpG oligodeoxynucleotides (ODNs) are known to stimulate adult B cell proliferation and immunoglobulin production.
  • Neonatal immune responses are generally immature and less responsive to certain antigens, like thymus-independent polysaccharides.

Purpose of the Study:

  • To investigate the response of neonatal human B cells to CpG-ODNs.
  • To compare the immunoglobulin production of neonatal B cells stimulated with CpG-ODNs to that of adult B cells.

Main Methods:

  • Umbilical cord blood cells and adult peripheral blood B cells were isolated.
  • Cells were stimulated with CpG-ODNs.
  • Immunoglobulin (IgM, IgG, IgA) production was measured using ELISA.

Main Results:

  • Both adult and umbilical cord B cells produced comparable amounts of IgM in response to CpG-ODN stimulation.
  • CpG-ODN stimulated IgG and IgA production in adult B cells, but cord blood cells produced significantly less IgG and no detectable IgA.
  • CpG-ODN induced IgM production in adult CD27-negative B cells, potentially explaining the response in naive cord B cells.

Conclusions:

  • CpG-ODNs can stimulate IgM production in neonatal human B cells, including responses to pneumococcal polysaccharide antigens.
  • The differential production of IgG and IgA suggests limitations in neonatal B cell responses to CpG-ODN stimulation.
  • CpG-ODNs show promise as neonatal vaccine adjuvants for polysaccharide antigens that are typically poorly immunogenic in infants.